ORCID

An international open science consultant and research infrastructure expert, Nabil has spent many years advancing higher education systems, open access repositories, and persistent identifier infrastructures across Africa and the Middle East.

With extensive experience in enterprise systems, community leadership, and strategic engagement with global initiatives such as ORCID, he has become a leading voice in the development of trusted, interoperable, and sustainable scholarly infrastructure.

Through his work, Nabil has championed innovative infrastructure integrations that connect African researchers to global knowledge networks while supporting the stewardship and visibility of indigenous and local knowledge.

His efforts continue to shape how open science, digital infrastructure and evidence-based scholarship contribute to equitable development, research excellence and innovation across the continent.

Exactly, the DockID, yes.

Right, so like before we talk about DockID, it's very important to understand that in Africa, we still do not have a good adoption of systems repository and institutional you know, warehouses where we can store our data, right? That's a common problem in Africa, right? So DocID in very simple terms is the digital identity and documentation tool framework for knowledge, right? It's not only a platform.

We are really trying to create sort of a conversation, sort of an infrastructure that can talk to other infrastructures and federate knowledge in it, right? So just as people have, you know, passports and researchers have, you know, ORCID IDs, knowledge, you know, objects also need to, you know, some trusted identities.

And these objects can include research outputs, data sets, and just knowledge records, you know, cultural heritage collections.

Yeah, maybe next time I have him on.

Do you know Kathy Tai of the ORCID?

Not personally.

I know friends who know her.

But I didn't want to sign this letter because of three reasons.

Number one, in order to sign the letter, you have to log in with your ORCID account, which I don't keep track of the password.

I got too many passwords.

There are way too many journal passwords.

But this study was posted in 2021.

So I used ORCID to go through his studies and found a study in 2021, which lists that he has consulted for Amgen, AstraZeneca, Boehringer-Ingelheim, Eli Lilly, NAP, Novo Nordisk, Sanofi, and Pfizer, and received grant funding from Boehringer-Ingelheim.

Now, Dr. Sattar is also the chair of the UK, quote, Obesity Healthcare Goals Program.

The website states, quote, working in partnership with the Scottish Government's Chief Scientist Office, the, quote, obesity healthcare goals are also funding a cardiometabolic, quote, obesity prevention study, or COPS.